Clin2
NCT06052176Possibly a fitActive, not recruiting

Albumin for better thinking in liver disease

CirrhosisHepatic Encephalopathy

Treatments studied

Part of Brain & nervous system, Digestive system, Hormones & metabolism clinical trials.

This trial tests if weekly albumin infusions can improve thinking problems (called hepatic encephalopathy) in people with cirrhosis. You may be eligible if you have cirrhosis, some memory or concentration issues, and have been taking lactulose or rifaximin for at least a month.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
25 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are over 18 years old.
  • You have cirrhosis (confirmed by a biopsy, scan, or certain lab results).
  • You have mild thinking or memory problems (like trouble with attention or slow thinking).
  • You have been taking lactulose or rifaximin for at least one month to control hepatic encephalopathy.
  • Your albumin level in the blood is below 4 g/dL.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06953921Recruiting
Liver disease and confusion: does albumin level matter?

This study looks at whether low albumin levels in the blood are linked to more severe confusion caused by liver disease. It may help doctors understand how to better manage hepatic encephalopathy.

Sohag
NCT07418008Recruiting
Thinking and memory study for people with liver cirrhosis

This study is creating a new test to measure thinking and memory problems in people with liver cirrhosis. It may help doctors find these problems earlier.

Ambāla, Haryana
NCT04096014Recruiting
Protein supplement at night to prevent repeat brain episodes

This study tests whether taking extra protein in the late evening or early morning can lower the chance of being readmitted for hepatic encephalopathy, a brain problem that can happen with liver disease. It may help by supporting safer nutrition and reducing the risk of another hospitalization.

Cleveland, Ohio
NCT06538077Recruiting· Phase 4
BCAA vs. Rifaximin to Prevent Recurrent Hepatic Encephalopathy

This trial compares two treatments—BCAA supplements and rifaximin—to see which is better at preventing another episode of confusion or coma in people with cirrhosis who have already had one. If you qualify, you would receive one of these treatments for several months.

Chandigarh
NCT06425380Recruiting
Resistant potato starch for liver cirrhosis and confusion

This study is testing whether a special type of starch (resistant potato starch) can help people with cirrhosis who have had episodes of confusion from liver problems. It may help by changing the bacteria in your gut, which could reduce the risk of future confusion episodes.

Rochester, Minnesota
NCT06812390Recruiting· Phase 2
Albumin plus diuretics for cirrhosis-related leg swelling

This study tests whether giving albumin (a protein) along with water pills helps reduce leg swelling in people with cirrhosis and ascites. It may be an option if your leg swelling hasn't improved with standard diuretics alone.

West Haven, Connecticut

Hear when a new Cirrhosis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.